Recent advances in innovative magnetic nanomaterials for cancer theranostics /

In this book, cancer theranostics applications of magnetic iron oxide nanoparticles are overviewed in detail. Moreover, their synthesis, characterization, multifunctionality, disease targeting, biodistribution, pharmacokinetics and toxicity have been briefly highlighted. Finally, we have mentioned t...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor principal: Mukherjee, Sudip (Autor)
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Bristol [England] (Temple Circus, Temple Way, Bristol BS1 6HG, UK) : IOP Publishing, [2019]
Colección:IOP (Series). Release 6.
IOP expanding physics.
IOP series in photomedicine and biophotonics.
Temas:
Cancer > Diagnosis.
Cancer > Treatment.
Nanostructured materials > Magnetic properties.
Nanostructured materials > Therapeutic use.
Biomedical engineering.
Neoplasms > therapy.
Neoplasms > diagnosis.
Magnetite Nanoparticles > therapeutic use.
Nanostructures > therapeutic use.
Biosensing Techniques.
Nursing specialties.
MEDICAL / Nursing / Oncology & Cancer.
Acceso en línea:Texto completo
Tabla de Contenidos:
  • 1. Introduction
  • 1.1. Cancer and statistics
  • 1.2. Conventional therapies for cancer and their limitations
  • 1.3. Alternative theranostics strategy: nanomedicine
  • 1.4. Magnetic nanoparticles and cancer theranostics
  • 2. Magnetic iron oxide nanoparticles: types, synthesis and characterization
  • 2.1. Common types of magnetic nanomaterials and their synthesis
  • 2.2. Characterization techniques
  • 2.3. Multilayer concept
  • 3. Magnetic nanoparticles for cancer diagnostics
  • 3.1. MRI
  • 3.2. Multimodal imaging
  • 3.3. Biosensors
  • 3.4. Cell labeling and monitoring of cancer treatments
  • 4. Magnetic iron oxide based nanoparticles for cancer therapeutics
  • 4.1. Drug delivery
  • 4.2. Magnetic hyperthermia
  • 4.3. Photothermal ablation
  • 4.4. Photodynamic therapy (PDT)
  • 4.5. MNPs as anti-cancer agent
  • 4.6. MNPs in cancer immunotherapy
  • 5. Safety of magnetic iron oxide nanomaterials, challenges, future scope and conclusion
  • 5.1. Pharmacokinetics, biodistribution, toxicity
  • 5.2. Targeting
  • 5.3. Magnetic nanoparticles as FDA approved or in clinical trials
  • 5.4. Challenges, future scopes and conclusion.

Ejemplares similares